Gilead Sciences (United States)
In research, Gilead Sciences (United States) stands highest in Life Sciences (#1,412 of 7,800 worldwide), Medicine (#2,296 of 10,443 worldwide) and Infectious Diseases (#91 of 345 worldwide), 2022–2025. Relative to its size it is most specialised in Hepatology, Infectious Diseases and Immunology and Microbiology — Hepatology is 27.8× its share of world research.
- World rank, 2022–2025
- #3,031 of 28,054 · #2,260 all time
- Rank in United States
- #432 of 4,192
- Research works
- 2.1k ▼ 3% vs 2013–17
- Citations
- 81k 38.3 per fractional work
- Top-10% rate
- 20.4% record average 16.5%
- Open access
- 47% world 28%
What is Gilead Sciences (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #1,412 of 7,800 | 22.5% | 106 | #961 | |
| MedicineField | #2,296 of 10,443 | 21.7% | 309 | #1704 | |
| Infectious DiseasesSubfield | #91 of 345 | 29.9% | 76 | #93 | |
| Health SciencesDomain | #3,211 of 11,982 | 21.6% | 320 | #2250 |
Each strip is that field’s whole ranked pool, with the notch where Gilead Sciences (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#961 #1,412
- Medicine#1,704 #2,296
- Infectious Diseases#93 #91
- Health Sciences#2,250 #3,211
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Gilead Sciences (United States) specialise in?
Where its research is concentrated relative to its size: Hepatology takes 27.8× the share of its output that it takes of world research.
- HepatologySubfield · 27.0 works28×
- Infectious DiseasesSubfield · 76.1 works22×
- Immunology and MicrobiologyField · 36.7 works7.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.8×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 8.8×
- Immunology and Microbiology 7.2×
- Mathematics 3.3×
- Medicine 3.2×
- Biochemistry, Genetics and Molecular Biology 1.8×
- Veterinary 1.6×
- Chemistry 1.6×
- Decision Sciences 1.1×
- Economics, Econometrics and Finance 1.1×
- Health Professions 0.7×
- Nursing 0.2×
- Neuroscience 0.2×
- Materials Science 0.2×
- Computer Science 0.2×
- Chemical Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Environmental Science 0.1×
- Business, Management and Accounting 0.1×
- Psychology 0.1×
- Arts and Humanities 0.1×
- Engineering 0.1×
- Dentistry 0.1×
- Social Sciences 0.1×
- Earth and Planetary Sciences 0.0×
- Energy 0.0×
- Physics and Astronomy 0.0×
Who are the top researchers at Gilead Sciences (United States)?
Ranked on the composite score, Michael D. Miller, Anu Osinusi and John G. McHutchison lead among researchers whose main affiliation is Gilead Sciences (United States).
- 1 Michael D. Miller · #19,354 worldwide 376 citations · 51 works
- 2 Anu Osinusi · #32,395 worldwide 971 citations · 33 works
- 3 John G. McHutchison · #42,027 worldwide 390 citations · 111 works
- 4 Anuj Gaggar · #44,010 worldwide 268 citations · 54 works
- 5 Diana M. Brainard · #61,418 worldwide 237 citations · 40 works
- 6 G. Mani Subramanian · #72,348 worldwide 247 citations · 31 works
- 7 Adrian S. Ray · #108,691 worldwide 265 citations · 26 works
- 8 Robert H. Hyland · #123,959 worldwide 202 citations · 22 works
- 9 Jason K. Perry · #139,607 worldwide 1.2k citations · 19 works
- 10 Tomáš Cihlář · #176,653 worldwide 197 citations · 27 works
Which keywords describe research at Gilead Sciences (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Antiretroviral Therapy, Immune Response, Epidemiology, HIV Infection, Vaccine, Antiviral Therapy, Liver Disease and Hepatotoxicity.
- NAFLD
- Chronic Hepatitis B
- Prognostic Factors
- neurocognitive disorders
- Immune Activation
- Biomarkers
- Hepatitis C Virus
- SARS-CoV-2
- Pandemic
- Stigma and Discrimination
- Insulin Resistance
- HIV Transmission
- Genetic Variation
- Hepatocellular Carcinoma
- Integrase Inhibitors
- Drug Resistance
- Liver Disease
- Antiviral Therapy
- HIV Infection
- Immune Response
- Antiretroviral Therapy
- Epidemiology
- Vaccine
- Inflammation
- Hepatotoxicity
- Adverse Effects
- Nucleoside Analogues
- Treatment
- Mortality Rates
- Viral Load
- Preexposure Prophylaxis
- HIV
- Chemotherapy
- Antibodies
- Ribavirin
- ACE2 Receptor
- AIDS
- Pathogenesis
- Hepatic Steatosis
- Hepatitis B Virus
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Antiretroviral Therapy80▲ 98×6 topics
- Immune Response63▲ 22×15 topics
- Epidemiology62▲ 3.1×61 topics
- HIV Infection38▲ 74×3 topics
- Vaccine33▲ 16×11 topics
- Antiviral Therapy33▲ 66×3 topics
- Inflammation32▲ 3.0×49 topics
- Liver Disease31▲ 66×3 topics
- Hepatotoxicity31▲ 123×2 topics
- Drug Resistance29▲ 21×6 topics
- Adverse Effects28▲ 116×2 topics
- Integrase Inhibitors28▲ 260×1 topic
- Nucleoside Analogues28▲ 260×1 topic
- Hepatocellular Carcinoma26▲ 25×3 topics
- Treatment25▲ 4.2×23 topics
- Genetic Variation25▲ 23×5 topics
- Mortality Rates25▲ 53×2 topics
- HIV Transmission25▲ 67×2 topics
- Viral Load25▲ 62×2 topics
- Insulin Resistance24▲ 10×7 topics
- Preexposure Prophylaxis24▲ 98×1 topic
- Stigma and Discrimination24▲ 98×1 topic
- HIV22▲ 53×4 topics
- Pandemic19▲ 3.6×7 topics
- Chemotherapy18▲ 5.0×17 topics
- SARS-CoV-218▲ 11×4 topics
- Antibodies17▲ 62×2 topics
- Hepatitis C Virus17▲ 101×1 topic
- Ribavirin17▲ 101×1 topic
- Biomarkers17▲ 5.0×14 topics
- ACE2 Receptor17▲ 14×2 topics
- Immune Activation16▲ 41×2 topics
- AIDS16▲ 127×1 topic
- neurocognitive disorders16▲ 127×1 topic
- Pathogenesis15▲ 5.9×14 topics
- Prognostic Factors14▲ 6.5×9 topics
- Hepatic Steatosis13▲ 17×2 topics
- Chronic Hepatitis B13▲ 76×1 topic
- Hepatitis B Virus13▲ 76×1 topic
- NAFLD13▲ 21×1 topic
Which research topics does Gilead Sciences (United States) publish most on?
By volume in 2022–2025: HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, Hepatitis C virus research and HIV Research and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 HIV/AIDS drug development and treatmentInfectious Diseases 28 works
- 2 HIV/AIDS Research and InterventionsInfectious Diseases 24 works
- 3 Hepatitis C virus researchHepatology 17 works
- 4 HIV Research and TreatmentVirology 16 works
- 5 Hepatitis B Virus StudiesEpidemiology 13 works
- 6 Liver Disease Diagnosis and TreatmentEpidemiology 13 works
- 7 HIV-related health complications and treatmentsEmergency Medicine 11 works
- 8 Drug Transport and Resistance MechanismsOncology 10 works
- 9 COVID-19 Clinical Research StudiesInfectious Diseases 10 works
- 10 Statistical Methods in Clinical TrialsStatistics and Probability 8 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Gilead Sciences (United States)'s research output changed?
Output in 2018–2022 was 3% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Foster City
- Visa (United States)
- SciClone Pharmaceuticals (United States)
- Interdisciplinary Dental Education Academy
- Notable Labs (United States)
- TeraRecon (United States)
- Guidewire (United States)
- Apollomics (United States)
- Active Spectrum (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.